Dpp-4 Inhibitors and Drug Safety: Post-market Surveillance Data
In recent years, Dpp-4 inhibitors have become a popular class of medications for managing type 2 diabetes. These drugs work by blocking the enzyme dipeptidyl peptidase-4, which results in increased levels of incretin hormones that help regulate blood sugar levels. Overview of Dpp-4 Inhibitors Common Dpp-4 inhibitors include sitagliptin, saxagliptin, linagliptin, and alogliptin. They are … Read more